ATE361742T1 - Verwendung von seifen wie magnesium stearate zur beschleunigung der freisetzung von wirkstoffen - Google Patents
Verwendung von seifen wie magnesium stearate zur beschleunigung der freisetzung von wirkstoffenInfo
- Publication number
- ATE361742T1 ATE361742T1 AT03011028T AT03011028T ATE361742T1 AT E361742 T1 ATE361742 T1 AT E361742T1 AT 03011028 T AT03011028 T AT 03011028T AT 03011028 T AT03011028 T AT 03011028T AT E361742 T1 ATE361742 T1 AT E361742T1
- Authority
- AT
- Austria
- Prior art keywords
- soaps
- accelerate
- release
- active ingredients
- magnesium stearate
- Prior art date
Links
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 235000019359 magnesium stearate Nutrition 0.000 title 1
- 239000000344 soap Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03011028A EP1479380B1 (de) | 2003-05-19 | 2003-05-19 | Verwendung von Seifen wie Magnesium Stearate zur Beschleunigung der Freisetzung von Wirkstoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE361742T1 true ATE361742T1 (de) | 2007-06-15 |
Family
ID=33040940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03011028T ATE361742T1 (de) | 2003-05-19 | 2003-05-19 | Verwendung von seifen wie magnesium stearate zur beschleunigung der freisetzung von wirkstoffen |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1479380B1 (de) |
| AR (1) | AR044379A1 (de) |
| AT (1) | ATE361742T1 (de) |
| DE (1) | DE60313745T2 (de) |
| WO (1) | WO2004100931A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT511581A1 (de) * | 2011-05-26 | 2012-12-15 | G L Pharma Gmbh | Orale retardierende formulierung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2928769A (en) * | 1957-07-22 | 1960-03-15 | Strong Cobb And Company Inc | Production of controlled release medicaments |
| FR1397102A (fr) * | 1959-12-31 | 1965-04-30 | Haessle Ab | Moyen pour l'obtention de préparations comprimées médicamenteuses ou alimentairesse désagrégeant rapidement en solution aqueuse |
| US3957662A (en) * | 1972-08-08 | 1976-05-18 | Hoffmann-La Roche Inc. | Pharmaceutical lubricants |
| IL112106A0 (en) * | 1993-12-22 | 1995-03-15 | Ergo Science Inc | Accelerated release composition containing bromocriptine |
| DE19916383A1 (de) * | 1999-03-31 | 2000-10-05 | Schering Ag | Pharmazeutische Zusammensetzung mit einem Extrusionsstoff |
| RU2188000C1 (ru) * | 2001-09-27 | 2002-08-27 | Нестерук Владимир Викторович | Лекарственное средство на основе тамоксифена |
| US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
-
2003
- 2003-05-19 AT AT03011028T patent/ATE361742T1/de active
- 2003-05-19 EP EP03011028A patent/EP1479380B1/de not_active Expired - Lifetime
- 2003-05-19 DE DE60313745T patent/DE60313745T2/de not_active Expired - Lifetime
-
2004
- 2004-04-06 WO PCT/EP2004/003651 patent/WO2004100931A2/en not_active Ceased
- 2004-05-18 AR ARP040101710A patent/AR044379A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1479380B1 (de) | 2007-05-09 |
| WO2004100931A3 (en) | 2005-08-18 |
| AR044379A1 (es) | 2005-09-07 |
| DE60313745T2 (de) | 2008-01-24 |
| EP1479380A1 (de) | 2004-11-24 |
| DE60313745D1 (de) | 2007-06-21 |
| WO2004100931A2 (en) | 2004-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY166613A (en) | Glycerol levulinate ketals and their use | |
| PT1773312E (pt) | Composição contendo estatinas e ácidos graxos ómega-3 | |
| CL2007002867A1 (es) | Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras. | |
| DE602005009866D1 (de) | Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden | |
| DE602005018601D1 (de) | Verfahren zur herstellung von 2-aminothiazol-5-aro | |
| GEP20074078B (en) | Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use | |
| CL2008001879A1 (es) | Compuestos derivados de isaxolinas-naftalen-carboamida; y el uso de los compuestos en el control de plagas de invertebrados en animales. | |
| BRPI0414463A (pt) | ácidos heteroarilbenzofuránicos substituìdos | |
| DE50312948D1 (de) | Alicyclische ester mit moschusgeruch | |
| CL2004001473A1 (es) | Procedimiento para producir neuronas desde celulas mesenquimatosas no diferenciadas y composicion que las contiene. | |
| ATE343605T1 (de) | Zusammensetzungen zur herstellung von aminoplasterzeugnissen | |
| EP1500693A4 (de) | Schmiermittelzusammensetzung | |
| DE602004031065D1 (de) | Komplementäre Implantationen zur Vermeidung der Ausweitung des Übergangs für die Herstellung ultraflacher Übergänge | |
| EP1767612A4 (de) | Festseifenzusammensetzung und feste seife | |
| DE502005003251D1 (de) | Verwendung von menadione zur verstärkung der wirksamkeit von agrochemikalien | |
| ITMI20041763A1 (it) | Nuove formulazioni iniettabili contenenti progesterone | |
| DE60330775D1 (de) | Verfahren zur Herstellung von Hydroperoxiden | |
| DE502005003027D1 (de) | Elektrolysezelle zur herstellung von alkalimetall | |
| CL2004001921A1 (es) | Compuestos derivados de pirimidina; composicion que los cintoene utiles como insecticidas y antihelminticos. | |
| ATE361742T1 (de) | Verwendung von seifen wie magnesium stearate zur beschleunigung der freisetzung von wirkstoffen | |
| EA201070257A1 (ru) | Ароматизированная терапевтическая композиция на основе глины | |
| DE602005010025D1 (de) | Verfahren zur Herstellung von Salicylestern | |
| DE602004005239D1 (de) | Verfahren zur herstellung von tubulininhibitoren | |
| DE602005000377D1 (de) | Verfahren zur herstellung von n-alkyl-pyrrolidonen | |
| JP2003119489A5 (ja) | 香料成分としての第三アルコールまたはエステルの使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1479380 Country of ref document: EP |